Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: January 6, 2005
Last updated: January 12, 2015
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)